-transparent.png){kind=logo}
Modulators for the reversal of multidrug resistance such as R-verapamil and B8509-035, a dihydropyridine, effectively overcome multidrug resistance in vitro and are currently undergoing clinical trial. One problem with their use is the application protocol; the question as to whether they should be given by continuous administration or in sequential doses in combination with the cytotoxic drugs has to be addressed. Therefore, we examined the influence of the exposure time and the sequence of modulator administration on the active transport of the fluorescent dye rhodamine 123 (R123), a substrate for the P-glycoprotein, in the resistant lymphoblastoid cell line VCR1000 and the parental nonresistant cell line CCRF-CEM. Our results demonstrate the importance of coadministration of R-verapamil and the cytotoxic agent for the modulation of multidrug resistance, whereas the exposure sequence does not seem to be such an essential parameter in the case of B8509-035. This observation should be considered for the further design of clinical studies.
E Roller, and
B Klumpp, and
J Krause, and
M Eichelbaum, and
K Schumacher
August 2003,
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],
E Roller, and
B Klumpp, and
J Krause, and
M Eichelbaum, and
K Schumacher
January 1994,
Anticancer research,
E Roller, and
B Klumpp, and
J Krause, and
M Eichelbaum, and
K Schumacher
September 1988,
Photochemistry and photobiology,
E Roller, and
B Klumpp, and
J Krause, and
M Eichelbaum, and
K Schumacher
January 1990,
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group,
E Roller, and
B Klumpp, and
J Krause, and
M Eichelbaum, and
K Schumacher
November 1972,
International journal of cancer,
E Roller, and
B Klumpp, and
J Krause, and
M Eichelbaum, and
K Schumacher
March 2004,
Toxicology letters,
E Roller, and
B Klumpp, and
J Krause, and
M Eichelbaum, and
K Schumacher
January 1986,
Anticancer research,
E Roller, and
B Klumpp, and
J Krause, and
M Eichelbaum, and
K Schumacher
January 1998,
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
E Roller, and
B Klumpp, and
J Krause, and
M Eichelbaum, and
K Schumacher
January 1994,
European journal of cancer (Oxford, England : 1990),
E Roller, and
B Klumpp, and
J Krause, and
M Eichelbaum, and
K Schumacher
January 2012,
Critical reviews in eukaryotic gene expression,
